Keyword search

Filter results by

Search Help
Currently selected filters that can be removed

Keyword(s)

Survey or statistical program

40 facets displayed. 0 facets selected.

Content

1 facets displayed. 0 facets selected.
Sort Help
entries

Results

All (661)

All (661) (0 to 10 of 661 results)

  • Articles and reports: 82-003-X202600500001
    Description: Previous research has found variability in cancer incidence and cancer-related outcomes according to place of residence. This study examined geographic variability in the incidence and mortality of breast cancer among females in Canada, using data from the 2021 Canadian Cancer Registry (breast cancer incidence) and the Canadian Vital Statistics – Death database (breast cancer mortality). Age-standardized incidence rates (ASIRs) and age-standardized mortality rates (ASMRs) per 100,000 females per year and their rate ratios were calculated, as well as age group-specific and age-standardized stage-specific incidence rates, and examined across provinces and territories, community sizes, and peer groups (i.e., clusters of health regions with similar socioeconomic and demographic characteristics).
    Release date: 2026-05-20

  • Articles and reports: 82-003-X202600500002
    Description: Breast cancer is the most commonly diagnosed cancer among women in Canada. Breast density substantially influences breast cancer risk and mammography performance. However, OncoSim-Breast, a Canadian microsimulation model representing breast cancer control, including cancer onset, screening, and survival, has not previously explicitly accounted for breast density. This study describes the incorporation of density-specific parameters—prevalence, relative risk of breast cancer, and digital mammography performance (sensitivity and specificity)—using data from five Canadian provinces, into the OncoSim-Breast model. Calibration experiments and internal validations were conducted to ensure the updated OncoSim-Breast model aligned with observed data from the Canadian Cancer Registry.
    Release date: 2026-05-20

  • Stats in brief: 11-627-M2026019
    Description: This infographic explores trends in Canadians’ weight over time, as well as how obesity may impact health.
    Release date: 2026-04-09

  • Articles and reports: 82-003-X202600300001
    Description: Body mass index (BMI) is commonly used to estimate obesity prevalence; however, reliance on BMI alone can lead to an incomplete understanding of obesity’s impact on health. In line with the 2025 recommendations of the Lancet Diabetes & Endocrinology Commission, this study used measured and self-reported data from the 2016 to 2019 Canadian Health Measures Survey to combine population-level measures of excess adiposity with indicators of physiological dysfunction and activity limitation across eight body system domains. Clinical and preclinical obesity were characterized by excess adiposity and progressive obesity-related impairment among Canadian adults.
    Release date: 2026-03-18

  • Table: 13-10-0326-01
    Geography: Canada
    Frequency: Occasional
    Description: Cardiovascular health measures of the household population, by sex and age group.
    Release date: 2026-03-10

  • Table: 13-10-0111-01
    Geography: Canada, Province or territory
    Frequency: Annual
    Description:

    Number and rate of new cancer cases diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

    Release date: 2026-02-27

  • Table: 13-10-0747-01
    Geography: Canada, Province or territory
    Frequency: Annual
    Description:

    The number of new cases, age-standardized rates and average age at diagnosis of cancers diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Cancer incidence rates are age-standardized using the direct method and the final 2011 Canadian postcensal population structure. Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

    Release date: 2026-02-27

  • Table: 13-10-0141-01
    Geography: Canada
    Frequency: Annual
    Description: Number of deaths caused by certain infectious and parasitic diseases, by age group and sex, 2000 to most recent year.
    Release date: 2026-01-13

  • Table: 13-10-0142-01
    Geography: Canada
    Frequency: Annual
    Description: Number of deaths caused by neoplasms, by age group and sex, 2000 to most recent year.
    Release date: 2026-01-13

  • Table: 13-10-0144-01
    Geography: Canada
    Frequency: Annual
    Description: Number of deaths caused by endocrine, nutritional and metabolic diseases, by age group and sex, 2000 to most recent year.
    Release date: 2026-01-13
Data (226)

Data (226) (40 to 50 of 226 results)

  • Table: 13-10-0867-01
    Geography: Canada
    Frequency: Occasional
    Description: Long term symptoms were defined as having COVID-19 symptoms at least 3 months after a self-reported positive test or suspected SARS-CoV-2 infection. Results on the status of long-term symptoms only included respondents for whom a period of three months separated their self-reported date of infection and the date they completed the questionnaire.
    Release date: 2023-08-03

  • Table: 13-10-0868-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Occasional
    Description: This survey provides new evidence about those who indicated on their electronic questionnaire a positive test result with either a positive polymerase chain reaction (PCR) test or a rapid antigen test (RAT), as well as those who suspected that they had an infection. These results are based on the individual's self-reported first positive test result or first suspected infection and does not account for multiple infections.
    Release date: 2023-08-03

  • Table: 35-10-0194-01
    Geography: Canada, Province or territory
    Frequency: Annual
    Description: Incident-based fire statistics, by type of casualty, age group of casualty, status of casualty, cause of death or injury and reason for non-evacuation, Canada, Nova Scotia, New Brunswick, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon, Canadian Armed Forces, 2005 to 2021.
    Release date: 2023-06-08

  • Table: 35-10-0195-01
    Geography: Canada, Province or territory
    Frequency: Annual
    Description: Incident-based fire statistics, by type of casualty, age group of casualty, status of casualty and type of structure, Canada, Nova Scotia, New Brunswick, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon, Canadian Armed Forces, 2005 to 2021.
    Release date: 2023-06-08

  • Table: 35-10-0196-01
    Geography: Canada, Province or territory
    Frequency: Annual
    Description: Incident-based fire statistics, by performance of smoke alarm device, residential fires and type of incident and casualty, Canada, Nova Scotia, New Brunswick, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon, Canadian Armed Forces, 2005 to 2021.
    Release date: 2023-06-08

  • Table: 35-10-0197-01
    Geography: Canada, Province or territory
    Frequency: Annual
    Description: Incident-based fire statistics, by performance of sprinkler system, structural fires and type of incident and casualty, Canada, Nova Scotia, New Brunswick, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon, Canadian Armed Forces, 2005 to 2021.
    Release date: 2023-06-08

  • Public use microdata: 13-25-0009
    Description: This public use microdata file (PUMF) provides researchers access to data on the distribution of SARS-CoV-2 lineages detected in the Canadian provinces between May and September 2022. Samples were collected as part of the Canadian COVID-19 Antibody and Health Survey (CCAHS), Cycle 2. The PUMF file consists of a subset of participants of the CCAHS who submitted a positive PCR saliva sample over the course of the collection of the survey. The PUMF contains select demographic information including sex at birth, age group, province and the week of collection. The file also contains SARS-CoV-2 whole genome sequences and its associated data.
    Release date: 2023-05-25

  • Table: 13-10-0840-01
    Frequency: Occasional
    Description:

    Annual percent change and average annual percent change in age-standardized cancer incidence rates since 1984 to the most recent diagnosis year. The table includes a selection of commonly diagnosed invasive cancers, as well as in situ bladder cancer. Cases are defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3) from 1992 to the most recent data year and on the International Classification of Diseases, ninth revision (ICD-9) from 1984 to 1991.

    Release date: 2023-05-16

  • Table: 13-10-0865-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Semi-annual
    Description: This table presents a series of indicators relating to the COVID-19 pandemic, including relating to perceptions of Canadians' mental health, precautions they've taken, willingness to receive vaccine and the number of vaccinated and unvaccinated persons. Estimates are based on preliminary bi-annual data from the Canadian Community Health Survey, and are provided for the Canadian population aged 18 and older excluding the territories, by region of residence and other demographic characteristics.
    Release date: 2023-04-25

  • Table: 13-10-0866-01
    Geography: Canada, Geographical region of Canada, Province or territory
    Frequency: Occasional
    Description: Dried blood spot testing was used to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. The proportion of Canadians who have antibodies from infection is referred to as the seroprevalence of SARS-CoV-2.
    Release date: 2023-03-27
Analysis (414)

Analysis (414) (70 to 80 of 414 results)

  • Articles and reports: 82-003-X202000900001
    Description:

    This study examine sexual behaviours, condom and other contraceptive use, and reasons for non-use by selected characteristics.

    Release date: 2020-09-16

  • Articles and reports: 82-003-X202000500001
    Description:

    This study examines Canadians' concerns about the impact of COVID-19 on their own health and the health of others, and the precautions individuals have taken to avoid infection.

    Release date: 2020-07-02

  • Articles and reports: 82-003-X202000300002
    Description: The purpose of this study was to assess the risk of non accidental and cause specific mortality associated with long term exposure to PM2.5 among immigrants after they arrived in Canada, and to assess how this risk compares with that of the non immigrant population. Using the Canadian Census Health and Environment Cohort, this study also sought to determine the influence of several immigrant specific variables on the PM2.5 -mortality association, including duration in Canada, country of birth, age at immigration and neighbourhood ethnic concentration.
    Release date: 2020-06-17

  • Stats in brief: 11-627-M2020028
    Description:

    This infographic presents new measures of labour market participation developed to help measure the impact of the COVID-19 pandemic on the Canadian labour market.

    Release date: 2020-04-09

  • Articles and reports: 82-003-X202000100002
    Description:

    Using data from the Canadian Cancer Registry, this study examines thyroid cancer (TC) incidence from 1992 to 2016. It presents sex-specific incidence estimates according to age, histology and province for the most recent five-year period (2012 to 2016), and examines changes in rates over the entire period. These findings are supplemented with similar information on TC mortality and five-year net survival.

    Release date: 2020-01-15

  • Stats in brief: 11-627-M2019072
    Description:

    This infographic covers actively serving Department of National Defence Canadian Armed Forces (DND-CAF) members from both the Regular Forces and Class A, B and C Primary Reserve.The findings are based on the Canadian Armed Forces Health Survey and the objective is to provide insight into the current health status of Canadian Armed Forces personnel.

    Release date: 2019-12-04

  • Stats in brief: 11-627-M2019078
    Description:

    This infographic covers Canadians aged 15 years and over whose everyday activities are limited because of a pain-related disability.

    Release date: 2019-12-03

  • Articles and reports: 82-003-X201900900002
    Description: The purpose of this study is to examine the association between walkability and obesity and self-rated general and mental health in a nationally-representative sample of Canadians in children and adults. A secondary purpose is to examine and describe the mediating effect of physical activity in the association between walkability and obesity. Data are from the 2016 Canadian Active Living Environments database and the Canadian Health Measures Survey (2009-2015).
    Release date: 2019-09-18

  • Stats in brief: 11-627-M2019066
    Description:

    This infographic presents findings on the association between walkable neighbourhoods and physical activity by age and type of physical activity, as well as the association between walkability and obesity.

    Release date: 2019-09-18

  • Articles and reports: 82-003-X201900800002
    Description:

    The Canadian Health Measures Survey (CHMS) provides a unique opportunity to examine the characteristics of the population with unperceived hearing loss-a term that refers to those who do not self-report a hearing impairment despite having some audiometrically measured hearing loss. Data from cycles 3 (2012 to 2013) and 4 (2014 to 2015) of the CHMS were combined and used to examine the adult population aged 40 to 79 years with unperceived hearing loss. The analysis describes the prevalence of audiometrically measured hearing loss and self-reported hearing impairment. The prevalence of unperceived hearing loss was examined by selected sociodemographic, health and other characteristics.

    Release date: 2019-08-21
Reference (21)

Reference (21) (0 to 10 of 21 results)

  • Surveys and statistical programs – Documentation: 82-225-X200701010508
    Description:

    The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

    Release date: 2008-01-18

  • Surveys and statistical programs – Documentation: 82-225-X
    Description:

    The compendium of Canadian Cancer Registry procedures manuals set out the rules for reporting cancer data to the CCR for all provincial and territorial cancer registries.

    Release date: 2008-01-18

  • Surveys and statistical programs – Documentation: 82-225-X20070109648
    Description:

    The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

    Release date: 2007-06-21

  • Surveys and statistical programs – Documentation: 82-225-X20070109650
    Description:

    The User Guide to Record Linkage Feedback Reports C1 and C2 is intended for the users of the reports. The reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

    Release date: 2007-06-21

  • Surveys and statistical programs – Documentation: 82-225-X20060099202
    Description:

    The User Guide to Record Linkage Feedback Reports C1 and C2 is intended for the users of the reports. The reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

    Release date: 2006-07-07

  • Surveys and statistical programs – Documentation: 82-225-X20060099203
    Description:

    The user guide to Death Clearance Feedback Reports is intended for users of the feedback reports. The feedback reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

    Release date: 2006-07-07

  • Surveys and statistical programs – Documentation: 82-225-X20060099204
    Description:

    The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

    Release date: 2006-07-07

  • Surveys and statistical programs – Documentation: 82-225-X20060099205
    Description:

    The Death Clearance Overview document describes the Death Clearance module of the Canadian Cancer Registry, its structure, its function and its role in the operation of the national cancer registry. Inputs and outputs are listed and briefly described, as well as the different steps constituting the Death Clearance process.

    Release date: 2006-07-07

  • Surveys and statistical programs – Documentation: 82-225-X20060099206
    Description:

    The Guidelines for Abstracting and Determining Death Certificate Only Cases are intended for use by all provincial and territorial cancer registries during their Death Clearance Process. The guidelines should be used when performing a comparison between the Death Certificate Notification and the cancer registry database.

    Release date: 2006-07-07

  • Surveys and statistical programs – Documentation: 82-619-M2006003
    Description:

    This document examines the functional limitations, physical, emotional and social, related to the musculoskeletal conditions having the largest impact on the health of Canadians. These functional limitations are described and classified using the Classification and Measurement System of Functional Health (CLAMES).

    These descriptions and classifications are the first step in a new approach to measuring the health of Canadians that examines what factors are adversely affecting population health and how to address them. This document also provides health professionals, advocacy groups, and individual Canadians with an overview of how living with certain musculoskeletal conditions affects day-to-day functioning.

    Release date: 2006-04-04